
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Therapeutic promise of engineered nonsense suppressor tRNAs
Joseph J. Porter, Christina S. Heil, John D. Lueck
Wiley Interdisciplinary Reviews - RNA (2021) Vol. 12, Iss. 4
Open Access | Times Cited: 53
Joseph J. Porter, Christina S. Heil, John D. Lueck
Wiley Interdisciplinary Reviews - RNA (2021) Vol. 12, Iss. 4
Open Access | Times Cited: 53
Showing 26-50 of 53 citing articles:
Optimization of Anticodon Edited Transfer RNAs (ACE-tRNAs) Function in Translation for Suppression of Nonsense Mutations
Joseph J. Porter, Wooree Ko, Emily G. Sorensen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Joseph J. Porter, Wooree Ko, Emily G. Sorensen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Suppressor tRNAs at the interface of genetic code expansion and medicine
Aya Awawdeh, Alexander A. Radecki, Oscar Vargas‐Rodriguez
Frontiers in Genetics (2024) Vol. 15
Open Access | Times Cited: 2
Aya Awawdeh, Alexander A. Radecki, Oscar Vargas‐Rodriguez
Frontiers in Genetics (2024) Vol. 15
Open Access | Times Cited: 2
Developing AAV-delivered nonsense suppressor tRNAs for neurological disorders
Jiaming Wang, Guangping Gao, Dan Wang
Neurotherapeutics (2024) Vol. 21, Iss. 4, pp. e00391-e00391
Open Access | Times Cited: 2
Jiaming Wang, Guangping Gao, Dan Wang
Neurotherapeutics (2024) Vol. 21, Iss. 4, pp. e00391-e00391
Open Access | Times Cited: 2
tRNA modifications and tRNA-derived small RNAs: new insights of tRNA in human disease
Di Wu, Xiuling Li, Faheem Ahmed Khan, et al.
Cell Biology and Toxicology (2024) Vol. 40, Iss. 1
Open Access | Times Cited: 2
Di Wu, Xiuling Li, Faheem Ahmed Khan, et al.
Cell Biology and Toxicology (2024) Vol. 40, Iss. 1
Open Access | Times Cited: 2
Features of CFTR mRNA and implications for therapeutics development
JaNise J. Jackson, Yiyang Mao, Tyshawn R. White, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 6
JaNise J. Jackson, Yiyang Mao, Tyshawn R. White, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 6
Cystic fibrosis
Isabelle Fajac, Pierre‐Régis Burgel
La Presse Médicale (2023) Vol. 52, Iss. 3, pp. 104169-104169
Open Access | Times Cited: 6
Isabelle Fajac, Pierre‐Régis Burgel
La Presse Médicale (2023) Vol. 52, Iss. 3, pp. 104169-104169
Open Access | Times Cited: 6
Seryl-tRNA synthetase promotes translational readthrough by mRNA binding and involvement of the selenocysteine incorporation machinery
Ze Liu, Justin Wang, Yi Shi, et al.
Nucleic Acids Research (2023) Vol. 51, Iss. 19, pp. 10768-10781
Open Access | Times Cited: 6
Ze Liu, Justin Wang, Yi Shi, et al.
Nucleic Acids Research (2023) Vol. 51, Iss. 19, pp. 10768-10781
Open Access | Times Cited: 6
Anticodon sequence determines the impact of mistranslating tRNA Ala variants
Ecaterina Cozma, Megha Rao, Madison Dusick, et al.
RNA Biology (2023) Vol. 20, Iss. 1, pp. 791-804
Open Access | Times Cited: 6
Ecaterina Cozma, Megha Rao, Madison Dusick, et al.
RNA Biology (2023) Vol. 20, Iss. 1, pp. 791-804
Open Access | Times Cited: 6
Genetics of Cystic Fibrosis
Anya T. Joynt, Garry R. Cutting, Neeraj Sharma
Clinics in Chest Medicine (2022) Vol. 43, Iss. 4, pp. 591-602
Closed Access | Times Cited: 8
Anya T. Joynt, Garry R. Cutting, Neeraj Sharma
Clinics in Chest Medicine (2022) Vol. 43, Iss. 4, pp. 591-602
Closed Access | Times Cited: 8
Genetic Interaction of tRNA-Dependent Mistranslation with Fused in Sarcoma Protein Aggregates
Jeremy T. Lant, Farah Hasan, Julia Briggs, et al.
Genes (2023) Vol. 14, Iss. 2, pp. 518-518
Open Access | Times Cited: 4
Jeremy T. Lant, Farah Hasan, Julia Briggs, et al.
Genes (2023) Vol. 14, Iss. 2, pp. 518-518
Open Access | Times Cited: 4
Emerging medicines to improve the basic defect in cystic fibrosis
Isabelle Fajac, Isabelle Sermet‐Gaudelus
Expert Opinion on Emerging Drugs (2022) Vol. 27, Iss. 3, pp. 229-239
Closed Access | Times Cited: 7
Isabelle Fajac, Isabelle Sermet‐Gaudelus
Expert Opinion on Emerging Drugs (2022) Vol. 27, Iss. 3, pp. 229-239
Closed Access | Times Cited: 7
Translation termination codons in protein synthesis and disease
Silvia Lombardi, Maria Francesca Testa, Mirko Pinotti, et al.
Advances in protein chemistry and structural biology (2022), pp. 1-48
Closed Access | Times Cited: 7
Silvia Lombardi, Maria Francesca Testa, Mirko Pinotti, et al.
Advances in protein chemistry and structural biology (2022), pp. 1-48
Closed Access | Times Cited: 7
Efficient suppression of premature termination codons with alanine by engineered chimeric pyrrolysine tRNAs
Aya Awawdeh, Alejandro Tapia, Sarah Alshawi, et al.
Nucleic Acids Research (2024) Vol. 52, Iss. 22, pp. 14244-14259
Open Access | Times Cited: 1
Aya Awawdeh, Alejandro Tapia, Sarah Alshawi, et al.
Nucleic Acids Research (2024) Vol. 52, Iss. 22, pp. 14244-14259
Open Access | Times Cited: 1
Optimization of ACE-tRNAs function in translation for suppression of nonsense mutations
Joseph J. Porter, Wooree Ko, Emily G. Sorensen, et al.
Nucleic Acids Research (2024)
Open Access | Times Cited: 1
Joseph J. Porter, Wooree Ko, Emily G. Sorensen, et al.
Nucleic Acids Research (2024)
Open Access | Times Cited: 1
RYR-1-Related Diseases International Research Workshop: From Mechanisms to Treatments Pittsburgh, PA, U.S.A., 21-22 July 2022
Thomas N. O’Connor, Luuk R. van den Bersselaar, Yu Seby Chen, et al.
Journal of Neuromuscular Diseases (2022) Vol. 10, Iss. 1, pp. 135-154
Open Access | Times Cited: 6
Thomas N. O’Connor, Luuk R. van den Bersselaar, Yu Seby Chen, et al.
Journal of Neuromuscular Diseases (2022) Vol. 10, Iss. 1, pp. 135-154
Open Access | Times Cited: 6
Ataluren prevented bone loss induced by ovariectomy and aging in mice through the BMP-SMAD signaling pathway
Lijun Zeng, Ranli Gu, Wei Li, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115332-115332
Open Access | Times Cited: 3
Lijun Zeng, Ranli Gu, Wei Li, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115332-115332
Open Access | Times Cited: 3
Therapeutic pipeline for individuals with cystic fibrosis with mutations nonresponsive to current cystic fibrosis transmembrane conductance regulator modulators
Isabelle Fajac, Isabelle Sermet‐Gaudelus
Current Opinion in Pulmonary Medicine (2021) Vol. 27, Iss. 6, pp. 567-574
Closed Access | Times Cited: 6
Isabelle Fajac, Isabelle Sermet‐Gaudelus
Current Opinion in Pulmonary Medicine (2021) Vol. 27, Iss. 6, pp. 567-574
Closed Access | Times Cited: 6
Nonsense Suppression Therapy: An Emerging Treatment for Hereditary Skin Diseases
Jiangfan Yu, Bingsi Tang, Xinglan He, et al.
Acta Dermato Venereologica (2022) Vol. 102, pp. adv00658-adv00658
Open Access | Times Cited: 4
Jiangfan Yu, Bingsi Tang, Xinglan He, et al.
Acta Dermato Venereologica (2022) Vol. 102, pp. adv00658-adv00658
Open Access | Times Cited: 4
Investigational new drugs for the treatment of Dravet syndrome: an update
Slobodan Јаnkovic, Snežana V. Janković, Radiša Vojinović, et al.
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 4, pp. 325-331
Closed Access | Times Cited: 2
Slobodan Јаnkovic, Snežana V. Janković, Radiša Vojinović, et al.
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 4, pp. 325-331
Closed Access | Times Cited: 2
RNA binding proteins PTBP1 and HNRNPL regulate CFTR mRNA decay
Amna Siddiqui, Arpit Saxena, Joshua Echols, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e22281-e22281
Open Access | Times Cited: 2
Amna Siddiqui, Arpit Saxena, Joshua Echols, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e22281-e22281
Open Access | Times Cited: 2
En route towards a personalized medicine approach: Innovative therapeutic modalities for connective tissue disorders
Charlene Redhead, Nandaraj Taye, Dirk Hubmacher
Matrix Biology (2023) Vol. 122, pp. 46-54
Open Access | Times Cited: 1
Charlene Redhead, Nandaraj Taye, Dirk Hubmacher
Matrix Biology (2023) Vol. 122, pp. 46-54
Open Access | Times Cited: 1
Anticodon Engineered Transfer RNAs (ACE-tRNAs) are a Platform Technology for Suppressing Nonsense Mutations
Wooree Ko, Joseph J. Porter, Sacha Spelier, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Wooree Ko, Joseph J. Porter, Sacha Spelier, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Small nuclear RNAs enhance protein-free RNA-programmable base conversion on mammalian coding transcripts
Aaron A. Smargon, Deepak Pant, Sofia Glynne, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Aaron A. Smargon, Deepak Pant, Sofia Glynne, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
A W1282X cystic fibrosis mouse allows the study of pharmacological and gene-editing therapeutics to restore CFTR function
M. Michicich, Zachary Traylor, C. P. McCoy, et al.
Journal of Cystic Fibrosis (2024)
Open Access
M. Michicich, Zachary Traylor, C. P. McCoy, et al.
Journal of Cystic Fibrosis (2024)
Open Access
<i>SCN2A</i>-Related Disorders
Megan Abbott, Kevin J. Bender, Andreas Brunklaus, et al.
Cambridge University Press eBooks (2024)
Open Access
Megan Abbott, Kevin J. Bender, Andreas Brunklaus, et al.
Cambridge University Press eBooks (2024)
Open Access